SEI Investments’s Immunovant IMVT Stock Holding History

SEI Investments’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$854K	Buy	22,160 +4,414	+25%	+$134K	﹤0.01%	2385
2026 Q1	$441K	Buy	17,746 +4,962	+39%	+$128K	﹤0.01%	2699
2025 Q4	$325K	Buy	+12,784	New	+$285K	﹤0.01%	2696
2025 Q2	–	Sell	-40,456	Closed	-$691K	–	2845
2025 Q1	$691K	Hold	40,456	–	–	﹤0.01%	2029
2024 Q4	$1M	Buy	40,456 +1,541	+4%	+$43.7K	﹤0.01%	1940
2024 Q3	$1.11M	Buy	+38,915	New	+$1.15M	﹤0.01%	1913
2024 Q2	–	Sell	-20,690	Closed	-$668K	–	2685
2024 Q1	$668K	Buy	20,690 +2,085	+11%	+$76.1K	﹤0.01%	2020
2023 Q4	$784K	Sell	18,605 -497	-3%	-$18.3K	﹤0.01%	1951
2023 Q3	$733K	Buy	+19,102	New	+$432K	﹤0.01%	1980
2021 Q3	–	Sell	-20,151	Closed	-$213K	–	2595
2021 Q2	$213K	Sell	20,151 -14,576	-42%	-$204K	﹤0.01%	2426
2021 Q1	$988K	Buy	34,727 +10,703	+45%	+$282K	﹤0.01%	1759
2020 Q4	$1.11M	Sell	24,024 -1,826	-7%	-$84.4K	﹤0.01%	1645
2020 Q3	$910K	Buy	+25,850	New	+$777K	﹤0.01%	1639

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SEI Investments's IMVT Position: Q2 2026 in Review

SEI Investments increased its Immunovant (IMVT) stake by 25% in Q2 2026, buying an estimated $134K and bringing the position to 22,160 shares worth $854K. The position accounts for ﹤0.01% of the portfolio, ranked #2385.

SEI Investments first reported a position in IMVT in Q3 2020 and has held it in 13 quarters since. The position peaked at $1.11M in Q4 2020. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

SEI Investments held 22,160 shares of Immunovant worth $854K as of Q2 2026.
SEI Investments bought 4,414 Immunovant shares in Q2 2026, an estimated $134K.
Immunovant made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2385 holding.
SEI Investments first reported a position in Immunovant in Q3 2020 and has held it in 13 quarters since.
SEI Investments's Immunovant position peaked at $1.11M in Q4 2020.
226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.